BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6601180)

  • 1. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.
    Sethi KK; Omata Y; Schneweis KE
    J Gen Virol; 1983 Feb; 64 (Pt 2)():443-7. PubMed ID: 6601180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection.
    Byrne JA; Oldstone MB
    J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
    Pfizenmaier K; Jung H; Starzinski-Powitz A; Röllinghoff M; Wagner H
    J Immunol; 1977 Sep; 119(3):939-44. PubMed ID: 70478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monoclonal antibodies directed against herpes simplex virus-specified glycoproteins on the generation of virus-specific and H-2-restricted cytotoxic T-lymphocytes.
    Sethi KK
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2033-7. PubMed ID: 6310041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.
    Larsen HS; Russell RG; Rouse BT
    Infect Immun; 1983 Jul; 41(1):197-204. PubMed ID: 6305838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological studies of herpetic keratitis: induction of cytotoxic T lymphocytes in mouse splenocytes.
    Hirakawa Y; Kondo H; Hiyama N; Sakata H
    Jpn J Ophthalmol; 1985; 29(3):241-9. PubMed ID: 3878428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
    Leung KN; Nash AA; Sia DY; Wildy P
    Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
    Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
    Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus.
    Baenziger J; Hengartner H; Zinkernagel RM; Cole GA
    Eur J Immunol; 1986 Apr; 16(4):387-93. PubMed ID: 3084281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.
    Witmer LA; Rosenthal KL; Graham FL; Friedman HM; Yee A; Johnson DC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():387-96. PubMed ID: 2155292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B; Allison AC
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo.
    Klavinskis LS; Tishon A; Oldstone MB
    J Immunol; 1989 Sep; 143(6):2013-6. PubMed ID: 2476492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity.
    Bonneau RH; Jennings SR
    J Virol; 1989 Mar; 63(3):1480-4. PubMed ID: 2536848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.